
In the late 1990's we worked with a Greek medical doctor
in Chicago -- (whose name we will not reveal) -- who reported
to us that he was having remarkable success treating colorectal
cancers using Cansema Tonic or diluted variations of Cansema Salve.

His method was novel: he
delivered the Cansema product using a catheter, which is would
insert through the rectum, having pre-measured the precise
distance the device would have to be inserted to be depositing
product in the exact area of the cancer. In so doing, this
method would have a success rate (he reasoned) that would
approximate the 99% we experienced when the Salve was used
directly on skin cancers.

Since that time, other
physicians (primarily in the third world) and end users have
adopted this technique, using an edema inserter or similar
system of delivery. There are, of course, a number of variations
to the protocols, though one common element is that frequent
"breaks" or "rests" are needed because even when diluted using
our pain management technique of
"cutting", there can be excessive irritation without them.

This note is made for
the benefit of certain researchers who wish to have a quick
brief on the history of this approach.
Cathryn Caton, N.D.
Alpha Omega Labs
Guayaquil, Ecuador
June 5, 2010